Skip to content

Camber launches generic Namenda

Camber Pharmaceuticals has added memantine HCl Tablets to its portfolio. The generic version of Namenda is indicated for the treatment of moderate to severe dementia of the Alzheimer’s type. Memantine HCl tablets are available in 5 and 10 mg strengths and supplied in 60-count bottles.

Table of Contents

PISCATAWAY, N.J. — Camber Pharmaceuticals has added memantine HCl Tablets to its portfolio. The generic version of Namenda is indicated for the

treatment of moderate to severe dementia of the Alzheimer’s type.

Memantine HCl tablets are available in 5 and 10 mg strengths and supplied in 60-count bottles.

More information about memantine HCl Tablets can be found at www.camberpharma.com.

Camber Pharmaceuticals is a fully integrated pharmaceutical company. Its parent company, Hetero, of Hyderabad, India, is one of the world’s leading API and finished dosage manufacturers. Camber is committed to bringing the highest quality generic pharmaceuticals to consumers, improving quality of life through cost-effective medications.

Comments

Latest